PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
159 hedge funds and large institutions have $612M invested in Progenics Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more capital invested
Capital invested by funds: $518M → $612M (+$93.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
159
Holding in Top 10
–
Calls
$6.1M
Puts
$3.62M
Top Buyers
| 1 | +$89.8M | |
| 2 | +$12.3M | |
| 3 | +$11.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$9.71M |
| 5 |
Goldman Sachs
New York
|
+$5.32M |
Top Sellers
| 1 | -$65.6M | |
| 2 | -$5.59M | |
| 3 | -$2.01M | |
| 4 |
RA
Royce & Associates
New York
|
-$1.97M |
| 5 |
PFC
Phocas Financial Corp
Alameda,
California
|
-$1.8M |